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We have used confocal and widefield microscopy to image
thrombus formation in real time in the microcirculation of a
living mouse. This system provides high-speed, near-simultaneous acquisition of images of multiple fluorescent probes and
of a brightfield channel. Vascular injury is induced with a laser
focused through the microscope optics. We observed platelet
deposition, tissue factor accumulation and fibrin generation
after laser-induced endothelial injury in a single developing
thrombus. The initiation of blood coagulation in vivo entailed
the initial accumulation of tissue factor on the upstream and
thrombus–vessel wall interface of the developing thrombus.
Subsequently tissue factor was associated with the interior of
the thrombus. Tissue factor was biologically active, and was associated with fibrin generation within the thrombus.
Blood coagulation is a host defense mechanism that maintains
the closed high-pressure circulatory system when blood-vessel
integrity is compromised. Pathologic processes, including inflammation and atherosclerosis, are associated with thrombus
formation. Occlusion of vessels and the resultant ischemia are
a principal cause of morbidity and mortality. Despite advances
in the understanding of platelet function, leukocyte adhesion,
blood coagulation and fibrinolysis from in vitro experiments,
knowledge of these processes in vivo has been limited by the
lack of direct observational tools. We have developed instrumentation for imaging real-time thrombus formation in the
microcirculation of a mouse using intravital high-speed confocal and widefield microscopy. This system provides nearly simultaneous acquisition of images of multiple fluorescent
probes and of data through a brightfield channel, and can deliver a laser-induced injury through the microscope optics.
With a laser-induced endothelial injury model1, we have studied the assembly of platelets, tissue factor and fibrin during
thrombus formation in vivo by fluorescence and brightfield microscopy. We used intravital microscopy to capture digital
videos of thrombotic events.
In vivo imaging during thrombus development
We infused fluorescent antibodies to label cellular and protein
components in the blood of a living mouse. Upon induction of
endothelial injury in a cremaster muscle arteriole, the accumulation of these antibodies in the developing thrombus can be
detected, imaged and quantified. In our study antibodies directed against CD41, a platelet-specific antigen, accumulated
in the thrombus (Fig. 1a). A brightfield image of the thrombus
in the microcirculation, a fluorescence image of labeled
platelets and a composite image showed the co-localization of
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platelets with the thrombus (Fig. 1a). When a control antibody
was used, no accumulation of fluorochrome in the thrombus
was seen (Fig. 1a). The integrated fluorescence intensity associated with the antibody against CD41 was significantly higher
than that associated with the control antibody (5.0 × 106 ± 1.2
× 106 as compared to 9.8 × 104 ± 0.5 × 104, average of ten independent experiments; P = 0.0002). Antibodies specific for fibrin
also accumulated in the thrombus (Fig. 1b). A brightfield
image, a fluorescence image and their composite showed co-localization of fibrin with the thrombus (Fig. 1b). Infusion with a
control antibody resulted in minimal fluorochrome accumulation in the thrombus. Comparing the integrated fluorescence
intensities associated with the antibody against fibrin and the
control antibody showed that there was minimal non-specific
accumulation of antibody within the thrombus (Fig. 1b). The
integrated fluorescence intensity associated with the antibody
against fibrin was significantly higher than that associated
with the control antibody were (3.4 × 106 ± 0.7 × 106 as compared to 3.3 × 105 ± 0.2 × 105, average of ten independent experiments; P = 0.0011).
Fluorescently labeled antibodies directed against tissue factor
accumulated in the thrombus (Fig. 1c). A brightfield image, a
fluorescence image and their composite image show the colocalization of tissue factor with the thrombus (Fig. 1c). A fluorescent control antibody did not accumulate in the thrombus.
Comparing the integrated fluorescence intensities associated
with the antibody against tissue factor and the control antibody showed limited non-specific incorporation of the irrelevant antibody into the thrombus. The integrated fluorescence
intensity associated with the antibody against tissue factor was
significantly higher than that associated with the control antibody (5.9 × 106 ± 1.1 × 106 as compared to 2.0 × 106 ± 0.5 × 106,
average of 12 independent experiments; (P = 0.0025). Parallel
experiments using Fab fragments of the antibody against tissue
factor yielded similar results (data not shown).
To examine the time course of platelet and fibrin accumulation in the developing thrombus, we labeled both platelets
and fibrin with fluorescently labeled antibodies. Widefield fluorescence images of platelet and fibrin deposition and a
brightfield image of the microcirculation showed co-localization of platelets and fibrin in the thrombus (Fig. 2a). The time
course of platelet and fibrin accumulation in three separate
experiments (Fig. 2b) showed that platelets accumulate rapidly
and the thrombus enlarges, then diminishes in size. After a lag
of about 15–20 seconds after endothelial injury, fibrin accumulated in the thrombus. Hirudin, an inhibitor of thrombin,
prevented the generation of fibrin in the developing throm1175
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Fig. 1 Imaging of platelets, fibrin
and tissue factor in arterial thrombi
using
fluorescent
antibodies.
Incorporation of fluorescence signals
into thrombi generated in wild-type
mice was analyzed. Left, integrated
fluorescence intensity over time for
representative
thrombi.
Right,
brightfield, fluorescence and composite images at 60 s after injury for
specific (lower) or control (upper)
antibody. Blood flow is from top to
bottom. a, Distribution of platelets,
detected with purified rat antibody
against mouse CD41 and Alexa
488–conjugated chicken anti-rat
IgG. Purified rat IgG1k and Alexa
488–conjugated chicken anti-rat IgG
were used in separate mice as control. b, Distribution of fibrin, detected
with
purified
mouse
anti-human fibrin-specific antibody
and Alexa 488–conjugated goat
anti-mouse IgG. Mouse IgG1k and
Alexa 488–conjugated goat antimouse IgG were used as control.
c, Distribution of tissue factor, detected with Alexa 488–labeled sheep
anti-rabbit tissue factor antibodies.
Alexa 488–labeled sheep IgG was
used as control.
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bus. Although the time course of tissue factor appearance was
of interest, tissue factor is a trace protein, and the signal-tonoise level was too low for us to be certain of the timing of tissue factor detection relative to the detection of platelets and
fibrin.
Confocal imaging of the developing thrombus
Intravital confocal images of fibrin and platelets were generated to determine the distribution of these components.
After endothelial injury, image sections of a thrombus were
acquired at 1-µm intervals across the vessel diameter by in-

crementally altering the working distance between the microscope objective and the specimen with a piezo-electric
driver. Representative sections are shown for a thrombus at
about 60 seconds after injury (Fig. 3a). These confocal slices
more accurately reveal the distribution of fibrin and platelets
within the thrombus than do the widefield images. Fibrin
appears with platelets near the top of the thrombus and
shows significant co-localization with platelets, although its
highest density is along the vessel wall and the upstream
edge of the thrombus. Tissue factor is distributed widely in
the thrombus, but is also concentrated along the throm-

a

15,000

b
Fig. 2 Time course and localization of platelets and fibrin during thrombus formation. Rat antibodies against mouse CD41 and chicken antibodies against Alexa
488–conjugated rat IgG were used to detect platelets. Fibrin was detected with Alexa
660–conjugated mouse antibody against human fibrin. a, Co-localization of platelets
and fibrin in a wild-type mouse in a thrombus 60 s after injury. Platelets (red), fibrin
(green), and platelets + fibrin (yellow) are in pseudocolors composited with brightfield (black/white). Blood flow is from top to bottom. b, Time course of incorporation
of platelets and fibrin into arterial thrombi of wild-type mice. Time courses are shown
for platelet and fibrin fluorescence incorporated into three separate thrombi over
time. Thrombi are labeled 1, 2 or 3; platelets are labeled A and fibrin is labeled B. The
experiments shown here are representative of 21 thrombi formed in 3 mice.
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Fig. 3 Confocal fluorescence imaging of the distribution of tissue factor,
platelets and fibrin in a thrombus. Confocal images of a thrombus 60 s after
injury were obtained by taking optical slices at 1-µm increments through approximately 80 µm. Images were collected in both the 488- and 647-nm
channels. Representative optical slices at 20-µm intervals are shown. The
panel labeled ‘20 µm’ represents the approximate center of the thrombus. a,
Fibrin was detected with Alexa 660–conjugated mouse antibody against
human fibrin, and platelets were detected using a combination of rat antibody against mouse CD41 and Alexa 488–conjugated chicken antibody
against rat IgG. Arrowheads indicate thrombus surface exposed to flowing
blood (brightfield image). Blood flow is from top to bottom. b, In a thrombus

60 s after injury, platelets were imaged with Alexa 660–conjugated rat antibody against mouse CD41 Fab, and tissue factor was detected with Alexa
488–conjugated sheep antibody against rabbit tissue factor. The vessel wall is
beneath the platelet thrombus (brightfield image). Blood flow is from right to
left. Fibrin or tissue factor image: fibrin or tissue factor depicted as red pseudocolor with full dynamic range of intensity; platelet image, platelets depicted as
green pseudocolor with full dynamic range of intensity; composite image,
merge (yellow) of red and green fluorescence channel with full dynamic
range of intensity; co-localization, all pixels containing both red and green
signals are presented in blue, without modulation for intensity. Confocal images are representative of 12 thrombi formed in 2 mice.

bus–vessel wall interface and the upstream edge of the
thrombus. In addition, although tissue factor and platelets
co-localize, the density of tissue factor is greatest along the
thrombus–vessel wall interface whereas the greatest density
of platelets is above the vessel wall (Fig. 3b).

Assembly of the developing thrombus
To compare the kinetics and localization of platelets, tissue
factor and fibrin in the thrombus in a living mouse, we carried
out intravital four-channel widefield fluorescence and brightfield imaging of these components (Fig. 4a). The composite
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seconds, the initial image immediately
after injury showed minimal fluorescence. At 4 seconds, platelets accumulated on the vessel wall. Tissue factor
was seen, but the signal-to-noise level
was too low for us to be certain whether
this initial signal was specific to tissue
factor. As the platelet thrombus expanded at 20 seconds, fibrin appeared
on the upstream edge of the thrombus.
At 26 seconds, platelet thrombus expansion continued as the quantity of
fibrin and tissue factor on the upstream
edge increased, whereas fibrin and tissue factor extended distally in the
thrombus. Between 34 and 60 seconds,
fibrin extended through much of the
platelet thrombus, although the downstream end of the thrombus remained
exclusively composed of platelets.

Discussion
With the application of confocal microscopy to the quantitative study of in
Tissue factor
vitro thrombus architecture2, the development of high-speed confocal microscopy3 and the use of laser-induced
endothelial
injury1, we developed an
46 s
8s
intravital microscopy system to image
thrombus formation in real time in the
microcirculation of living mice. We
used this instrumentation to explore
Composite
the assembly of platelets, tissue factor
and fibrin during thrombus formation
in a living mouse.
Tissue factor is the initial activator of
blood coagulation that culminates in
20 s
60 s
the generation of a fibrin clot4. A membrane protein, it is expressed on most
Fig. 4 Structural organization during thrombus development. Intravital widefield imaging of
non-vascular cells5,6. The classical model
platelet, tissue factor and fibrin deposition in the developing thrombus of a wild-type mouse after enhas been that vascular injury leads to
dothelial injury. Blood flow is from right to left. Alexa 660–conjugated CD41 Fab fragments, Alexa
the exposure of flowing blood to tissue
488–conjugated sheep antibody against tissue factor and Alexa 350–conjugated mouse antibodies
factor and rapid initiation of blood coagainst human fibrin were infused into the systemic circulation. a, Identification of thrombus comagulation. Yet low levels of tissue factor
ponents in four separate channels; black and white images are brightfield and pseudocolors reprecirculate in normal plasma7–9. Nemerson
sent the thrombus components. To simplify analysis of the composite image, the dynamic range of
used an in vitro thrombosis model, in
the intensity of each pseudocolor was minimized. b, Composite images of the developing thrombus.
which fresh human blood is perfused
Platelets (red); tissue factor (green); fibrin (blue); platelets + tissue factor (yellow); tissue factor + fibrin (turquoise); platelets + fibrin (magenta); platelets + fibrin + tissue factor (white). Using the fluointo a chamber to generate thrombi on
rochromes, excitation filters and bandpass filters described, there was no crossover of fluorescence in
collagen-coated slides or pig arterial
each of the fluorescence channels. These images are representative of experiments producing a total
medium, to show that tissue factor acof 14 thrombi in 3 mice. A videoclip of thrombus formation is available as Supplementary Movie 1
cumulates within the thrombus10.
online.
We observed platelet deposition, tissue factor localization and fibrin formation during thrombus formation in
four-channel image indicated that platelets are the principal mice after defined vascular injury of the arterial vessel wall.
component of the arterial thrombus. Fibrin was localized on We showed that tissue factor and fibrin were initially associthe upstream edge of the thrombus and then extended ated with the upstream aspect and vessel-wall interface of the
through about 75% of the thrombus during the period exam- thrombus, and propagated through the thrombus. Although
ined. Tissue factor was localized on the upstream edge of the observations of the confocal thrombus slices indicated that
fibrin and tissue factor were distributed throughout much of
thrombus and along the vessel-wall interface.
We monitored assembly of the developing arterial thrombus the thrombus volume, tissue factor was concentrated at the
by high-speed intravital four-channel imaging (Fig. 4b). At 0 thrombus–vessel wall interface. Indeed, some tissue factor was
1178
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Fig. 5 Schematic diagram of the confocal–widefield highspeed microscope used for real-time intravital microscopy of
the microcirculation of a living mouse. For widefield applications, epi-illumination is delivered by repositioning the light
path from a xenon lamp through one of 4 fixed excitation filters. Under computer control, excitation wavelengths can be
changed as rapidly as every 1.2 ms. Images can also be collected in a brightfield channel controlled by the Uniblitz shutter. Light incident from the sample passes through an
appropriate dichroic and emission filter, and the signal is enhanced by an image intensifier before being captured in the
CCD camera. For confocal applications, a krypton–argon
laser is filtered to deliver light of 488 nm, 568 nm or 647 nm.
The plane of confocal illumination is changed by moving the
objective lens by means of a piezo-electric motor under software control. The signal is also enhanced by an image intensifier before being captured in the CCD camera. Injury is
initiated in the microvasculature by a nitrogen pulse dye laser.
The light is coherent but not focused until it reaches the focal
point of the objective; in this way light can be passed through
intermediate tissue without damaging it. The confocal component is used to eliminate out-of-focus haze, to obtain 2-dimensional slices through the thrombus and to construct 3-dimensional optical
images based upon stacking of image slices. The widefield microscope is used for the

Methods
Preparation of mice for intravital microscopy. Mice were
pre-anesthetized by intraperitoneal injection of ketamine, xylazine and atropine sulfate. Nembutal was administered
through the jugular vein. The cremaster muscle was exteriorized in 4–7 min in preparation for intravital microscopy11,12.
Antibodies in 200 µl of physiologic saline were infused through
a jugular vein cannulus. All procedures were approved by the
Animal Care and Use Committee of the Beth Israel Deaconess
Medical Center.
Laser-induced vessel-wall injury. Between 5 and 60 min after
antibody infusion, arterioles were identified and endothelial injury induced using a pulsed nitrogen dye laser at 440 nm applied through the microscope objective using the Micropoint
laser system (Photonics Instruments, St. Charles, Illinois).
Arterioles with a diameter of 30–60 µm were targets for injury.
Multiple (6–10) independent experiments were done over the
course of approximately 1 h.
Antibodies and reagents. To detect tissue factor, mice were
infused with sheep antibody against rabbit tissue factor labeled
with Alexa 488 (8 µg/g body weight; American Diagnostica,
Greenwich, Connecticut), or with sheep IgG labeled with
Alexa-488 (8 µg/g body weight) as a control. To detect fibrin,
mouse antibody against the human fibrin IIβ chain (2 µg/g
body weight; Accurate Chemical, Westbury, New York), or
mouse IgG1k (2 µg/g body weight; BD Pharmingen, Palo Alto,
California) as a control, were pre-incubated before infusion
with goat antibody against mouse IgG conjugated to Alexa-488
(1 µg/g body weight). For some experiments, the fibrin antibody was directly labeled with Alexa-660 or Alexa-350. To detect platelets, rat antibody against mouse CD41 (0.1 µg/g body
weight; BD Pharmingen), or rat IgG1k (0.1 µg/g body weight;
BD Pharmingen) as a control, were pre-incubated before infusion with chicken antibody against rat IgG conjugated to Alexa488 (1 µg/g body weight). As indicated, CD41 Fab fragments
were labeled with Alexa-660. Alexa-350, Alexa-488 and Alexa-
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most rapid imaging, particularly when 4 channels are used. Exposure times are as
short as 10–15 ms. Hard drive with ample gigabytes of storage.

660 were conjugated to purified antibodies using the Alexa
Fluor Protein Labeling Kit (Molecular Probes, Eugene, Oregon)
according to the manufacturer’s instructions. Fab fragments of
antibodies were prepared using papain (Pierce, Rockford,
Illinois) and were labeled with Alexa dyes.
Intravital imaging. We have designed a high-speed confocal
and widefield microscope for intravital microscopy of the microcirculation of a living mouse (Fig. 5). This digital instrument
allows near-simultaneous collection of images in up to 4 separate channels, each with a different fluorescence or brightfield
image. We use an Olympus AX-70 fluorescence microscope
with a long-distance condenser; a ×60 (NA 0.9) water-immersion objective is mounted on a piezoelectric driver and its controller to allow the focal plane to be rapidly changed.
For confocal fluorescence microscopy we used the Yokogawa
CSU-10 confocal scanner (PerkinElmer, Gaithersburg,
Maryland). This system is equipped with an argon–krypton 3line laser for excitation at λex 488 nm, λex 568 nm, λex 647 nm
and a Sutter Lambda L-10 filter wheel (Novato, California) on
the excitation source. Widefield intravital microscopy was done
using a Sutter Lambda DG-4 high-speed wavelength changer
with a 175-watt xenon light source equipped with excitation
filters (360 nm, 480 nm and 590 nm) matched to a triple-band
filter for DAPI, FITC and Cy5 (Chroma, Brattleboro, Vermont) in
the body of the microscope. To provide a brightfield channel
while collecting image data in fluorescence channels, a Uniblitz
(Vincent Associates, Rochester, New York) shutter supplied
transmitted light. For both confocal and widefield imaging,
light was amplified using a Videoscope (Sterling, Virginia)
image intensifer. A Cooke SensiCam (Auburn Hills, Michigan)
CCD camera (640 × 480 format) allowed the capture of up to
60 frames/s using 2 × 2 binning. A Dell workstation was used
for synchronization of components, data acquisition and image
analysis. SlideBook software (Intelligent Imaging Innovations,
Denver, Colorado) was used for data capture, component control and image analysis. Statistical analyses were done using the
Student t-test.
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not co-localized with platelets but was adjacent to platelets
along the vessel wall. These in vivo studies can be distinguished from the observations of Giesen et al.10 who, on the
basis of an in vitro model using human blood, posited that the
propagation of blood coagulation might involve the accumulation of blood-borne tissue factor into the thrombus.
Although blood-borne tissue factor may indeed be an important component of the developing thrombus, concentration
of tissue factor along the thrombus–vessel wall interface and
adjacent regions of the vessel wall points to the vessel wall itself as a source of, and required participant in, tissue-factor accumulation. Further studies using this new intravital
technology and transgenic mice will address the origins of tissue factor. In addition, this instrumentation should be useful
as a means to directly examine and quantify the anti-thrombotic activity of new pharmaceuticals and understand the
pathogenesis of thrombi.
Note: Supplementary information is available on the Nature Medicine
website.
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